| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |